Navigation Links
New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue
Date:7/25/2014

Los Angeles, CA (PRWEB) July 25, 2014

In recent years, men have become more aware of, willing to talk about, and eager to reverse the symptoms associated with age-related testosterone decline. Amid concerns about testosterone and heart health in the media at large, a new case study from Renew Man helps to shed light on the real benefits of testosterone therapy using bioidentical hormones.

The case study centers around a patient named Jason, a 38-year-old father from Seattle who found himself beginning to feel the effects of age-related hormonal decline.

Jason described himself as a “skinny fatty,” who at 5’11” and 165 pounds had 18.5 percent body fat. Despite serious efforts to lose the weight on his own through healthy exercise, Jason was unable to shed this stubborn body fat.

Jason also found himself suffering from fatigue at work, where he relied on caffeine to get him through the day, and at home, where he lacked the energy to keep up with his active 7-year-old son.

After being referred to a Renew Man doctor, Jason learned that the symptoms he had been experiencing were the result of natural hormonal decline, specifically low testosterone. Under the care of a Renew Man doctor, Jason was able to reverse this testosterone decline and thereby eliminate his symptoms.

With regular blood work and twice-weekly treatments at home, plus adjustments to his diet and smoking habit, Jason’s testosterone increased nearly threefold to a safe and healthy level in just 6 months. His body fat decreased from 18.5 percent to 5.3 percent, and his energy was restored to the point where he reported he felt like he was 20 years old again.

It is important to note that there are several factors here that made this case study stand out from other testosterone treatments which have been linked with negative outcomes and health risks in the media.

First of all, Jason’s treatment used bioidentical hormones which are better accepted by the body than synthetic hormones. Secondly, these hormones were prescribed in customized doses designed not just to raise testosterone, but to raise it to a healthy level and keep it there. This ensured that the full benefits of healthy testosterone were felt. Finally, the entire treatment was administered under the supervision of an expert doctor using a delivery means that ensured a slow and steady supply of testosterone to the body and minimized the chance for estrogen conversion or other harmful side effects common in unsupervised treatments.

This case study supports the fact that testosterone therapy is safe and effective if done correctly by a qualified doctor and should give hope to men across the country who may be feeling the ill effects of low testosterone.

About Renew Man
Renew Man is a division of Renew Youth™ Centers. Since 1999, Renew Youth Centers have driven advancements in healthy aging & bioidentical hormone replacement therapy. The Renew Man network of skilled, experienced doctors meets clients’ exact needs with customized programs based on proven science. Each client’s program includes regular physician care to monitor progress and ensure safety. Because andropause is a medical condition, Renew Man stresses the importance of working with a doctor to replace hormones.

To learn more about Renew Man, call (800) 859-7511 or visit http://www.renewman.com today.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12049296.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate the ... will be an opportunity for area-residents to celebrate two great years while also ...
(Date:3/27/2017)... ... March 27, 2017 , ... The homeowner improvement and repair market ... utilizing DIY and unlicensed contractors for renovations is also on the rise. Per a ... 2015, and of those, 42% failed to use a licensed contractor.(2) The risks associated ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician ... 100 Award, a prestigious award honoring the top influencers on RealSelf—the most trusted ... connect with doctors and clinics. , In 2016, more than 82 million people ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce ... large subjects. The ELITE DXA has an active scan window, which is more than ... to fit in the scan area could not undergo an accurate total body bone density ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter established its ... time by providing Prehospital Trauma Life Support (PHTLS) course scholarships to four medics ... trauma education developed in cooperation with the American College of Surgeons to promote ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... HAYWARD, Calif. , March 27, 2017  Impax ... Directors has appointed Paul M. Bisaro as ... of the Company,s Board, effective March 27, 2017. Mr. ... has served as Interim President and Chief Executive Officer ... years of generic and branded pharmaceutical experience, Mr. Bisaro, ...
(Date:3/27/2017)... March 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), ... inherited liver diseases in children, today reported financial ... ended December 31, 2016 and provided an update ... continued to make progress during the fourth quarter ... from our non-human primate safety study, and with our ...
(Date:3/27/2017)... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... across multiple therapeutic areas, today announced that Amit Munshi , ... corporate update at the 16th Annual Needham Healthcare Conference on ... place April 4-5, 2017 at the Westin New York Grand ... A live audio webcast of the presentation will ...
Breaking Medicine Technology: